New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong
Oncology January 30,2024
An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

An unexpected T cell exhaustion factor driving cancer immunotherapy resistance

by The University of Hong KongGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111647A research team from the LKS Faculty of Medicine, the University of Hong
Oncology January 30,2024
Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainThe Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right
Oncology January 30,2024
Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

Continued access to fertility preservation is critical for teens and young adult cancer patients after SCOTUS decision

by American Cancer SocietyCredit: Pixabay/CC0 Public DomainThe Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right
Oncology January 30,2024
Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b
Oncology January 30,2024
Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

Study results show conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer

by Dana-Farber Cancer InstituteAntitumor activity of mirvetuximab soravtansine. (A) Maximum percentage change in target lesion size from baseline. Best response according to RECIST is indicated b
Oncology January 30,2024
One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA pooled analysis evaluating the 15-year effect of sigmoidoscopies has found that receiving one sigmoidoscopy significantly reduc
Oncology January 30,2024
One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainA pooled analysis evaluating the 15-year effect of sigmoidoscopies has found that receiving one sigmoidoscopy significantly reduc
Oncology January 30,2024
Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for yea
Oncology January 30,2024
Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

Long-term study supports link between inflammation and cognitive problems in older breast cancer survivors

by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainScientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for yea
Oncology January 30,2024
Researchers identify potential gene marker for treating pancreatic cancer

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre
Oncology January 30,2024
Researchers identify potential gene marker for treating pancreatic cancer

Researchers identify potential gene marker for treating pancreatic cancer

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicResearchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancre
Oncology January 30,2024
Study finds new, unexpected mechanism of cancer cell spread

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu
Oncology January 30,2024
Study finds new, unexpected mechanism of cancer cell spread

Study finds new, unexpected mechanism of cancer cell spread

by Keck School of Medicine of USCResearchers from the Keck School of Medicine of USC used imaging techniques to study how the protein GRP78 controls cancer cell behavior. In the top row, human lu
Oncology January 30,2024
Researchers find changes in blood proteins up to two years before breast cancer diagnosis

Researchers find changes in blood proteins up to two years before breast cancer diagnosis

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers have found changes in the levels of particular proteins in people's blood up to two years
Oncology January 30,2024
Researchers find changes in blood proteins up to two years before breast cancer diagnosis

Researchers find changes in blood proteins up to two years before breast cancer diagnosis

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers have found changes in the levels of particular proteins in people's blood up to two years
Oncology January 30,2024
Multi-modal AI models for intermediate- to high-risk localized prostate cancer

Multi-modal AI models for intermediate- to high-risk localized prostate cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910
Oncology January 30,2024
Multi-modal AI models for intermediate- to high-risk localized prostate cancer

Multi-modal AI models for intermediate- to high-risk localized prostate cancer

by NRG OncologyCredit: Pixabay/CC0 Public DomainNRG Oncology investigators analyzed clinical and digital histopathology data from five Phase III prostate cancer trials (NRG/RTOG 9202, 9408, 9413, 9910
Oncology January 30,2024
Researchers target commonly mutated or deleted gene in gynecological cancers

Researchers target commonly mutated or deleted gene in gynecological cancers

by Sbarro Health Research Organization (SHRO)FBXW7 isoforms and SCF-FBXW7 complex. (A) Three FBXW7 isoforms (α, β, and γ), which are structurally different only at their N-terminal region, while shari
Oncology January 30,2024
Researchers target commonly mutated or deleted gene in gynecological cancers

Researchers target commonly mutated or deleted gene in gynecological cancers

by Sbarro Health Research Organization (SHRO)FBXW7 isoforms and SCF-FBXW7 complex. (A) Three FBXW7 isoforms (α, β, and γ), which are structurally different only at their N-terminal region, while shari
Oncology January 30,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com